Abeona Therapeutics Inc.
NASDAQAbeona Therapeutics delivered a clean Q1 earnings beat this morning, but the short side is not moving. Revenue of $8.72M crushed the $4.57M consensus by a wide margin. EPS came in at -$0.30, five cents better than the -$0.35 estimate. Management reported continued expansion of its pz-cel treatment center network — the key commercial driver for its FDA-approved cell therapy for…
Snapshot as of 28 Jun 2026
Abeona Therapeutics delivered a clean Q1 earnings beat this morning, but the short side is not moving. Revenue of $8.72M crushed the $4.57M consensus by a wide margin. EPS came in at -$0.30, five cents better than the…
Abeona Therapeutics heads into its May 13 earnings call with one of the most extreme short setups in the biotech universe — and a 25% monthly price rally making that position increasingly uncomfortable. Short sellers…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABEO — free to start on ORTEX.
Sign up for free →Open ABEO on ORTEX